ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Diagnostic criteria"

  • Abstract Number: 1098 • ACR Convergence 2021

    Does Cancer Masquerade as Sarcoidosis?

    Daniel Albert, Dartmouth-Hitchcock, Etna, NH

    Background/Purpose: Several case reports have suggested that cancer can present occultly as a granulomatous inflammatory disease consistent with sarcoidosis. These cases illustrate a problem of…
  • Abstract Number: 1109 • ACR Convergence 2021

    Comparison of Diagnostic Criteria in Behçet’s Disease and Sensitivity in Diagnosing Severe Manifestations

    Carmen Álvarez-Reguera1, Alba Herrero-Morant1, Lara Sánchez-Bilbao1, David Martinez-Lopez1, José Luis Martin-Varillas2, Guillermo Suárez-Amorin1, Maria Cristina Mata-Arnaiz3, Miguel Ángel gonzalez-Gay4 and Ricardo Blanco5, 1Hospital Universitario Marqués de Valdecilla, Santander, Spain, 2Hospital Sierrallana, Torrelavega, Spain, 3Hospital de Laredo, Spain, Spain, 4Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla; School of Medicine, Universidad de Cantabria, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 5Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Behçet disease (BD) is characterized by painful recurrent oral aphthosis genital ulcers and skin lesions. Nevertheless, the major causes of morbidity result from ocular,…
  • Abstract Number: 1394 • ACR Convergence 2021

    Vascular Ultrasound for Giant Cell Arteritis: An Effective Diagnostic Modality for a Fast Track Clinic in the United States

    Charlie Oshinsky1, Alison Bays1, Ingeborg Sacksen2, Elizabeth Jernberg3, Eugene zierler1, Andreas Diamantopoulos4 and Scott Pollock1, 1University of Washington, Seattle, WA, 2University of Washington, Bellingham, WA, 3Virginia Mason Medical Center, Seattle, WA, 4Akerhus University Hospital, Brum, Norway

    Background/Purpose: Giant cell arteritis (GCA) is the most common form of large vessel vasculitis. Prompt diagnosis and treatment of GCA is vital to prevent vision…
  • Abstract Number: 1633 • ACR Convergence 2021

    Epidemiology of Musculoskeletal Manifestations in Paediatric Inflammatory Bowel Disease: A Systematic Review

    Aaisham Ali1, Melanie Schmidt2, David Piskin2, Eileen Crowley3 and Roberta Berard4, 1Schulich School of Medicine & Dentistry, London, ON, Canada, 2Lawson Health Research Institute, London, ON, Canada, 3Department of Paediatrics, Division of Paediatric Gastroenterology, Children's Hospital, London Health Sciences Centre, London, ON, Canada, 4London Health Sciences Centre, London, ON, Canada

    Background/Purpose: Paediatric inflammatory bowel disease (p-IBD) is a chronic and relapsing gastrointestinal disorder of childhood with associated long-term morbidity. Several extraintestinal manifestations (EIMs) are described,…
  • Abstract Number: 1849 • ACR Convergence 2021

    False Positive Anti-Topoisomerase I (Scl-70) Antibody Results: A Case Series from a Scleroderma Referral Center

    Brian Lam1, Rana Taherian1, Julio Charles1, Maureen Mayes2, Shervin Assassi3 and Brian Skaug4, 1Division of Rheumatology, University of Texas McGovern Medical School at Houston, Houston, TX, 2Division of Rheumatology and Clinical Immunogenetics, University of Texas McGovern Medical School, Houston, TX, 3University of Texas McGovern Medical School at Houston, Houston, TX, 4University of Texas McGovern Medical School Houston, Houston, TX

    Background/Purpose: Systemic sclerosis (SSc) is a progressive autoimmune disease with high morbidity and mortality, making early diagnosis and management critical. Anti-Topoisomerase I antibody (anti-Topo I,…
  • Abstract Number: 1921 • ACR Convergence 2021

    Axial Psoriatic Arthritis: Correlation Between Whole Spine MRI Abnormalities and Clinical Findings

    Pamela Diaz1, Iris Eshed2, Joy Feld3 and Lihi Eder1, 1University of Toronto, Toronto, ON, Canada, 2Sheba Medical Center, Ramat Gan, Israel, 3Carmel and Zvulun Medical Centre, Haifa, Israel

    Background/Purpose: Psoriatic Arthritis (PsA) typically affects peripheral joints, but in some patients the disease can involve the spine. While magnetic resonance imaging (MRI) is an…
  • Abstract Number: 1877 • ACR Convergence 2020

    Diagnosis of Axial Spondyloarthritis: A Primary Unmet Educational Need for Rheumatologists Is Interpretation of MRI

    Walter Maksymowych1, Liron Caplan2, Atul Deodhar3, Soha Dolatabadi4, Mark Hwang5, Adam Carlson6, Kelly Steed7, Amanda Carapellucci8, Joel Paschke8 and Lianne Gensler9, 1University of Alberta, Edmonton, AB, Canada, 2Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO, 3Oregon Health & Science University, Portland, OR, 4Soha Dolatabadi, MD, Los Angeles, CA, 5McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 6University of Virginia, Charlottesville, VA, 7James J. Peters VA Medical Center, Bronx, NY, 8CARE Arthritis, Edmonton, AB, Canada, 9University of California San Francisco, San Francisco, CA

    Background/Purpose: Diagnosis of axial spondyloarthritis (axSpA) is challenging because of absent physical findings in early disease and the limited diagnostic performance of laboratory markers. Considerable…
  • Abstract Number: 1893 • ACR Convergence 2020

    Predictors of Response in Secukinumab-treated Patients with Ankylosing Spondylitis: Logistic Regression and Machine Learning Analyses

    Corinne Miceli-Richard1, Denis Poddubnyy2, Atul Deodhar3, Weibin Bao4, Craig Parman5, Brian Porter6 and Effie Pournara5, 1Paris Descartes University, Department of Rheumatology - Hôpital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France, 2Charité – Universitätsmedizin Berlin, Berlin, Germany, 3Oregon Health & Science University, Portland, OR, 4Novartis Pharmaceuticals Corporation, East Hannover, 5Novartis Pharma AG, Basel, Switzerland, 6Novartis Pharmaceuticals Corporation, East Hanover, NJ

    Background/Purpose: Predicting outcomes early in the disease course in patients (pts) with ankylosing spondylitis (AS) is challenging, owing to heterogeneity of symptoms, varying disease severity,…
  • Abstract Number: 1939 • ACR Convergence 2020

    Definitions and Reliability Assessment of Chronic Ultrasound Lesions of the Axillary Artery in Giant Cell Arteritis: A Study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group

    Valentin Schaefer1, Stavros Chrysidis2, Greta Carrara3, Wolfgang Schmidt4, George A. Bruyn5, Bhaskar Dasgupta6, Eugenio De Miguel7, Andreas Diamantopoulos8, Christina Duftner9, Ulrich Fredberg10, Berit Nielsen11, Wolfgang Hartung12, Alojzija Hocevar13, Annamaria Iagnocco14, Aaron Juche4, Tanaz Kermani15, Tove Lorenzen16, Pierluigi Macchioni17, Marcin Milchert18, Uffe Døhn19, Sara Monti20, Chetan Mukhtyar21, Cristina Ponte22, Carlo Scire23, Lene Terslev24, Luca Seitz25 and Christian Dejaco26, 1Clinic of Internal Medicine III, Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Germany, Bonn, Nordrhein-Westfalen, Germany, 2Sydvestjysk Sygehus Esbjerg, Esbjerg, Denmark, 3Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy, 4Immanuel Krankenhaus Berlin Buch, Berlin, Germany, 5Rheumatology, Reumakliniek Lelystad, Lelystad, Netherlands, 6Rheumatology, Mid and South Essex University Hospital NHS Foundation Trust, Southend University Hospital, United Kingdom, Westcliff on sea, England, United Kingdom, 7Rheumatology Department, Hospital Universitario La Paz, Madrid, Spain, 8Martina Hansens Hospital, Baerum, Norway, 9Medical University Innsbruck, Innsbruck, Austria, 10Silkeborg Regional Hospital, Silkeborg, Denmark, 11Aarhus University Hospital, Aarhus, Denmark, 12Asklepios Klinik Bad Abbach, Bad Abbacg, Germany, 13University Medical Center, Rheumatology, Ljubljana, LJUBLJANA, Slovenia, 14Università degli Studi di Torino, Academic Rheumatology Centre, Turin, Italy, 15David Geffen School of Medicine / University of California, Los Angeles, CA, 16Copenhagen Center for Arthritis Research, Copenhagen, Denmark, 17Unità Operativa di Reumatologia/Arcispedale S. Maria Nuova, Reggio Emilia, Italy, 18Pomeranian Medical University, Szczecin, Poland, 19Center for Rheumatology and Spine Diseasesand COPECARE, Copenhagen, Denmark, 20Fondazione IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy, 21Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom, 22Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal, 23University of Ferrara, Ferrara, Italy, 24Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup., Copenhagen, Denmark, 25Department of Rheumatology, Immunology and Allergology, University of Bern, Inselspital, Switzerland, Bern, Switzerland, 26South Tyrol Health Trust, Hospital of Bruneck, Bruneck, Italy

    Background/Purpose: The OMERACT Ultrasound (US) large vessel vasculitis task force has recently defined the US appearance of normal axillary arteries (AA) and the key elementary…
  • Abstract Number: 0026 • ACR Convergence 2020

    A Modified Version of the 2016 ACR Fibromyalgia Criteria Cognitive Items Results in Stronger Correlation Between Subjective and Objective Measures of Cognitive Impairment

    Valerie Aloush1, Chen Yaalon2, Sheer Raev2, Noy Sobol2, Jacob Ablin1, Ran Shorer3 and Odelia Elkana2, 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Academic College Tel Aviv Jaffa, Tel Aviv, Israel, 3Tel Aviv Medical Center, Tel Aviv, Israel

    Background/Purpose: In a previous study, we showed that the subjective item assessing cognitive impairment (SSS-Cog) for fibromyalgia (FM) did not correlate with objective cognitive measures.…
  • Abstract Number: 2019 • ACR Convergence 2020

    Preliminary Definition of a Positive MRI for Active Lesions in the Sacroiliac Joints Typical of Axial Spondyloarthritis

    Walter Maksymowych1, Xenofon Baraliakos2, Ulrich Weber3, Pedro M Machado4, Susanne J Pedersen5, Joachim Sieper6, Stephanie Wichuk1, Denis Poddubnyy7, Martin Rudwaleit8, Désirée van der Heijde9, Robert Landewé10, Joel Paschke11, Mikkel Østergaard12 and Robert G Lambert13, 1University of Alberta, Edmonton, AB, Canada, 2Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany, 3University of South Denmark, Odense, Denmark, 4University College London, London, United Kingdom, 5Rigshospitalet University, Copenhagen, Denmark, 6Charité Universitätsmedizin Berlin, Berlin, Germany, 7Charité – Universitätsmedizin Berlin, Berlin, Germany, 8Department of Internal Medicine and Rheumatology, Klinikum Bielefeld, Germany, 9Leiden University Medical Center, Leiden, Netherlands, 10Amsterdam University Medical Center & Zuyderland Hospital, Amsterdam, Netherlands, 11CARE Arthritis, Edmonton, AB, Canada, 12Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, 13University of Alberta and CARE Arthritis, Edmonton, AB, Canada

    Background/Purpose: The ASAS definition of a positive MRI for inflammation (ASAS-MRI+) is intended for classification of patients as having axSpA but is often misused for…
  • Abstract Number: 0094 • ACR Convergence 2020

    Validation Study of Proposed Diagnostic Criteria for Sympathetic Joint Effusion

    Justin Levinson1, Mali Jurkowski2, Jasleen Kahlon3, Hayoung Youn4, Daohai Yu3 and Irene Tan5, 1Section of Rheumatology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, 2Temple University, Philadelphia, PA, 3Temple University, Philadelphia, 4Temple University Medical School, Philadelphia, 5Albert Einstein Healthcare Network, Philadelphia, PA

    Background/Purpose: Sympathetic joint effusion (SJE) is a rarely diagnosed rheumatologic entity characterized by painful yet non-inflammatory range synovial effusion. The condition was originally described in…
  • Abstract Number: 0159 • ACR Convergence 2020

    Patient-Reported Data Show the Impact of Time to Diagnosis in RA

    Kelly O'Neill1, Kathryne Marks2, John Davis3 and Cynthia Crowson4, 1Rheumatoid Patient Foundation, Orlando, FL, 2Rosalind Franklin University of Medicine and Science, North Chicago, IL, 3Mayo Clinic, Rochester, MN, 4Mayo Clinic, Rochester, Minnesota, USA, Rochester, MN

    Background/Purpose: Time from diagnosis to treatment has been well established to correlate with better outcomes in rheumatoid arthritis (RA). Treatment delays are often associated with…
  • Abstract Number: 0445 • ACR Convergence 2020

    Dual-Energy CT in Gout Patients: Do All Color-Coded Lesions Actually Represent Monosodium Urate Crystals?

    Sara Christiansen1, Felix Müller2, Mikkel Østergaard3, Ole Slot1, Jakob Møller2, Henrik Børgesen2, Kasper Gosvig2 and Lene Terslev4, 1Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup., Glostrup, Denmark, 2Department of Radiology, Herlev and Gentofte Hospital, Herlev, Denmark, 3Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, 4Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup., Copenhagen, Denmark

    Background/Purpose: Dual-Energy CT (DECT) can acknowledge differences in tissue compositions and can color-code tissues with specific features including monosodium urate (MSU) crystals. However, when evaluating…
  • Abstract Number: 0519 • ACR Convergence 2020

    Thrombotic and Obstetric Associations of Non-Criteria Antiphospholipid Immunoassays That Detect Antibodies to Neutral and Negatively-Charged Phospholipid

    Rohan Willis1, E Nigel Harris2, Vijaya Murthy3, Zurina Romay-Penabad1, Alvaro Schleh4, Monica Smikle2, Karel De Ceulaer2, Anne Tebo5, Troy Jaskowski6, Marta Guerra7, David Ware Branch8, Jane Salmon7, Michelle Petri9 and Emilio Gonzalez1, 1University of Texas Medical Branch, Galveston, TX, 2University of the West Indies, Kingston, Jamaica, 3University of Texas Medical Branch, League City, TX, 4Antiphospholipid Standardization Laboratory, GALVESTON, TX, 5Department of Pathology, University of Utah, Salt Lake City, 6ARUP Laboratories, Salt Lake City, UT, 7Hospital for Special Surgery, New York, NY, 8University of Utah, Salt Lake City, 9Johns Hopkins University School of Medicine, Baltimore

    Background/Purpose: Criteria antiphospholipid (aPL) antibodies that identify antiphospholipid syndrome (APS) patients, anticardiolipin (aCL) and anti-β2glycoprotein-I (anti-β2GPI), have demonstrated inconsistent specificity and sensitivity in this regard…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology